IPCA Laboratories Limited (IPCALAB) Price & Analysis

Compare

2 Followers

IPCALAB Stock Chart & Stats

₹1403.75

-₹42.20(-2.43%)

At close: Jan 08 4:00 PM EST

₹1403.75

-₹42.20(-2.43%)

Day’s Range― - ―

52-Week Range₹1,200.00 - ₹1,594.55

Previous CloseN/A

Volume578.66K

Average Volume (3M)6.78K

Market Cap

₹378.12B

Enterprise Value₹378.48B

Total Cash (Recent Filing)₹11.05B

Total Debt (Recent Filing)₹0.00

Price to Earnings (P/E)41.6

Beta0.53

Next Earnings

Jun 03, 2026

EPS Estimate

8.2

Next Dividend Ex-DateN/A

Dividend Yield0.28%

Share Statistics

EPS (TTM)12.20

Shares Outstanding253,659,230

10 Day Avg. Volume6,645

30 Day Avg. Volume6,776

Financial Highlights & Ratios

PEG Ratio1.37

Price to Book (P/B)5.08

Price to Sales (P/S)3.95

P/FCF Ratio70.64

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

₹1,755.00

Price Target Upside25.02% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering2

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Revenue GrowthConsistent revenue growth indicates strong market demand and effective sales strategies, supporting long-term business expansion and stability.

Balance Sheet HealthA strong equity ratio signifies financial stability and a robust capital structure, providing resilience against economic fluctuations.

Cash Flow ManagementPositive cash flow management ensures liquidity and the ability to fund operations and investments, crucial for sustainable growth.

Bears Say

Net Profit Margin FluctuationsFluctuating net profit margins can indicate instability in cost management and pricing strategies, affecting long-term profitability.

Inconsistent Free Cash Flow GrowthInconsistent free cash flow growth may hinder the company's ability to invest in new opportunities and manage financial obligations effectively.

Increased Debt LevelsRising debt levels can increase financial risk and limit flexibility, potentially impacting future investment and growth strategies.

IPCA Laboratories Limited News

Ipca Laboratories to Sell US Step-Down Subsidiary, Updates Registered Office Details for Project Filings

IPCA Laboratories Limited ( ($IN:IPCALAB) ) just unveiled an announcement. Ipca Laboratories’ board has approved the sale of...

1M ago

IPCA Laboratories Expands with New German Subsidiary

IPCA Laboratories Limited ( ($IN:IPCALAB) ) has shared an update. IPCA Laboratories Limited has announced the incorporation of...

4M ago

IPCA Laboratories Announces Trading Window Closure

IPCA Laboratories Limited ( ($IN:IPCALAB) ) has issued an announcement. IPCA Laboratories Limited has announced the closure of...

5M ago

IPCA Laboratories Confirms Compliance with SEBI Regulations for Q2 2025

The latest announcement is out from IPCA Laboratories Limited ( ($IN:IPCALAB) ). IPCA Laboratories Limited has submitted a...

8M ago

IPCALAB FAQ

What was IPCA Laboratories Limited’s price range in the past 12 months?

IPCA Laboratories Limited lowest stock price was ₹1200.00 and its highest was ₹1594.55 in the past 12 months.

What is IPCA Laboratories Limited’s market cap?

IPCA Laboratories Limited’s market cap is ₹378.12B.

When is IPCA Laboratories Limited’s upcoming earnings report date?

IPCA Laboratories Limited’s upcoming earnings report date is Jun 03, 2026 which is in 101 days.

How were IPCA Laboratories Limited’s earnings last quarter?

IPCA Laboratories Limited released its earnings results on Feb 13, 2026. The company reported ₹12.2 earnings per share for the quarter, beating the consensus estimate of ₹11.656 by ₹0.544.

Is IPCA Laboratories Limited overvalued?

According to Wall Street analysts IPCA Laboratories Limited’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does IPCA Laboratories Limited pay dividends?

IPCA Laboratories Limited pays a Semiannually dividend of ₹2 which represents an annual dividend yield of 0.28%. See more information on IPCA Laboratories Limited dividends here

What is IPCA Laboratories Limited’s EPS estimate?

IPCA Laboratories Limited’s EPS estimate is 8.2.

How many shares outstanding does IPCA Laboratories Limited have?

IPCA Laboratories Limited has 253,659,230 shares outstanding.

What happened to IPCA Laboratories Limited’s price movement after its last earnings report?

IPCA Laboratories Limited reported an EPS of ₹12.2 in its last earnings report, beating expectations of ₹11.656. Following the earnings report the stock price went up 0.891%.

Which hedge fund is a major shareholder of IPCA Laboratories Limited?

Currently, no hedge funds are holding shares in IN:IPCALAB

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

IPCA Laboratories Limited

Ipca Laboratories Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India. It offers APIs in therapeutic areas of anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic. The company provides generic and branded formulations in the therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, dermatology, diabetology, gastroenterology, haematology, neurology, ophthalmology, rheumatology, and urology, as well as respiratory, psychiatry, probiotics, orthopedics, oral anti diabetes drug, nutraceuticals, NSAIDs, neuropathic pain, malaria, infectious diseases, immunosuppressant, hepatoprotectives, helminthics, fever, and emollients/protectives. It exports its products to approximately 100 countries worldwide. The company was incorporated in 1949 and is based in Mumbai, India.

IPCA Laboratories Limited (IPCALAB) Earnings & Revenues

Historic Earnings Reports

IPCALAB Stock 12 Month Forecast

Average Price Target

₹1,755.00

▲(25.02% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1326":"₹1,326","1801":"₹1,801","1444.75":"₹1,444.8","1563.5":"₹1,563.5","1682.25":"₹1,682.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1800,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">₹1.80K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1755,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">₹1.75K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1710,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">₹1.71K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1326,1444.75,1563.5,1682.25,1801],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2025","6":"Mar<br/>2025","9":"Aug<br/>2025","12":"Feb<br/>2026","25":"Feb<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1439.8,1467.5076923076922,1495.2153846153847,1522.923076923077,1550.6307692307691,1578.3384615384616,1606.0461538461539,1633.753846153846,1661.4615384615386,1689.1692307692308,1716.876923076923,1744.5846153846155,1772.2923076923078,{"y":1800,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1439.8,1464.0461538461539,1488.2923076923078,1512.5384615384614,1536.7846153846153,1561.0307692307692,1585.2769230769231,1609.5230769230768,1633.7692307692307,1658.0153846153846,1682.2615384615385,1706.5076923076922,1730.753846153846,{"y":1755,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1439.8,1460.5846153846153,1481.3692307692306,1502.1538461538462,1522.9384615384615,1543.7230769230769,1564.5076923076922,1585.2923076923078,1606.076923076923,1626.8615384615384,1647.6461538461538,1668.4307692307693,1689.2153846153847,{"y":1710,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1486.58,"date":1727740800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1583.57,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1530.57,"date":1733011200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1694.5,"date":1735689600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1441,"date":1738368000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1441,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1351.57,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1421.28,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1370.1,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1449.99,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1365.85,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1327.8,"date":1759276800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1439.8,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >